Does sacituzumab-govitecan act as a conventional antibody drug conjugate (ADC), a prodrug of SN-38 or both?
@article{ATM73340, author = {Daniel V. Santi and Luc Cabel and François-Clément Bidard}, title = {Does sacituzumab-govitecan act as a conventional antibody drug conjugate (ADC), a prodrug of SN-38 or both?}, journal = {Annals of Translational Medicine}, volume = {9}, number = {14}, year = {2021}, keywords = {}, abstract = {}, issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/73340} }